Skip to Main Content

Author Details

Bart S Ferket
Institute for Healthcare Delivery Science, Icahn School of Medicine at Mount Sinai
2010
78
25
PMIDPaper TitleJournal TitlePublished Year
37897232Physician services and costs after disclosure of diagnostic sequencing results in the NYCKidSeq program.Genet Med2024
36567057Lessons learned while starting multi-institutional genetics research in diverse populations: A report from the Clinical Sequencing Evidence-Generating Research (CSER) consortium.Contemp Clin Trials2023
37220263Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression.Diabetes Care2023
36949526The TeleKidSeq pilot study: incorporating telehealth into clinical care of children from diverse backgrounds undergoing whole genome sequencing.Pilot Feasibility Stud2023
37470118Parent-Reported Clinical Utility of Pediatric Genomic Sequencing.Pediatrics2023
35168253Lifetime Cardiovascular Disease Risk by Coronary Artery Calcium Score in Individuals With and Without Diabetes: An Analysis From the Multi-Ethnic Study of Atherosclerosis.Diabetes Care2022
35833928Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods.Genet Med2022
34906461US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER).Genet Med2022
35331891Re-analysis of the Effect of Coronary Artery Bypass Surgery in Patients With Left Ventricular Dysfunction.J Card Fail2022
32583340Adoption and Trends in the Medicare New Technology Add-On Payment Program.J Gen Intern Med2021
33649905Effects of New York's Executive Order on Face Mask Use on COVID-19 Infections and Mortality: A Modeling Study.J Urban Health2021
33761758Estimating Long-Term Health Utility Scores and Expenditures for Cardiovascular Disease From the Medical Expenditure Panel Survey.Circ Cardiovasc Qual Outcomes2021
33593377Correction to: The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children.Trials2021
33844296To ban or not to ban tanning bed use for minors: A cost-effectiveness analysis from multiple US perspectives for invasive melanoma.Cancer2021
34543148Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.Radiology2021
34078663Long-term Predictions of Incident Coronary Artery Calcium to 85 Years of Age for Asymptomatic Individuals With and Without Type 2 Diabetes.Diabetes Care2021
33980040Estimated Health Care Utilization and Expenditures in Individuals With Heart Failure From the Medical Expenditure Panel Survey.Circ Heart Fail2021
34254851Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.Radiology2021
33161511Developing an Institute for Health Care Delivery Science: successes, challenges, and solutions in the first five years.Health Care Manag Sci2021
33446240The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children.Trials2021
33417490Cost-Effectiveness Analysis of Selective Internal Radiotherapy With Yttrium-90 Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma.JCO Oncol Pract2021
31375378Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation.J Thorac Cardiovasc Surg2020
32714777Trends and sociodemographic disparities in sugary drink consumption among adults in New York City, 2009-2017.Prev Med Rep2020
32601385Economic value of exome sequencing for suspected monogenic disorders.Genet Med2020
32588209Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.Eur Radiol2020
32401264Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals.JAMA Cardiol2020
32293643Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure.JAMA Cardiol2020
31109837The impact of pathologic response to neoadjuvant chemotherapy on conditional survival among patients with muscle-invasive bladder cancer.Urol Oncol2019
30081119Local radiation and phototherapy are the most cost-effective treatments for stage IA mycosis fungoides: A comparative decision analysis model in the United States.J Am Acad Dermatol2019
31200951Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis.Eur Urol2019
31220624Standardized Use of the Stanford Integrated Psychosocial Assessment for Transplantation in LVAD Patients.J Card Fail2019
31097163Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation.J Am Coll Cardiol2019
30801918Pathological downstaging as a novel endpoint for the development of neoadjuvant chemotherapy for upper tract urothelial carcinoma.BJU Int2019
31150110Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer.Cancer2019
29338858Cost-effectiveness analysis in cardiac surgery: A review of its concepts and methodologies.J Thorac Cardiovasc Surg2018
29879397Effectiveness of Transurethral Resection plus Systemic Chemotherapy as Definitive Treatment for Muscle Invasive Bladder Cancer in Population Level Data.J Urol2018
30734024Early Mortality in Patients With Muscle-Invasive Bladder Cancer Undergoing Cystectomy in the United States.JNCI Cancer Spectr2018
30336920Maximizing society's overall health in the face of budgetary constraints.J Thorac Cardiovasc Surg2018
29754910Lifestyle advice and interventions for cardiovascular risk reduction: A systematic review of guidelines.Int J Cardiol2018
28827404Acute Kidney Injury in Patients on SGLT2 Inhibitors: A Propensity-Matched Analysis.Diabetes Care2017
30657403Web-Based Tool to Facilitate Shared Decision Making With Regard to Neoadjuvant Chemotherapy Use in Muscle-Invasive Bladder Cancer.JCO Clin Cancer Inform2017
28279374The Quantitative Science of Evaluating Imaging Evidence.JACC Cardiovasc Imaging2017
28433377Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Are Things Now Getting Personal?Eur Urol2017
28301778Risk-stratified versus Non-Risk-stratified Diagnostic Testing for Management of Suspected Acute Biliary Obstruction: Comparative Effectiveness, Costs, and the Role of MR Cholangiopancreatography.Radiology2017
28077465Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease.Heart2017
28476763Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.J Am Soc Nephrol2017
28351833Impact of total knee replacement practice: cost effectiveness analysis of data from the Osteoarthritis Initiative.BMJ2017
28420342Impact of correlation of predictors on discrimination of risk models in development and external populations.BMC Med Res Methodol2017
28971982National Estimates of 30-Day Unplanned Readmissions of Patients on Maintenance Hemodialysis.Clin J Am Soc Nephrol2017
28852495Reasons for admission and predictors of national 30-day readmission rates in patients with end-stage renal disease on peritoneal dialysis.Clin Kidney J2017
  • 1 - 50 of 78

Recommended Authors

Cardiovascular medicine clinical fellow at the Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
National Institute for Health and Care Excellence
Career Start Year 2013
Number of shared co-authors 0
Griffin Hospital
Career Start Year 2012
Number of shared co-authors 0
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 3
Department of Health Services, Brown University School of Public Health
Career Start Year 2010
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2009
Number of shared co-authors 3
Feinberg School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 1
Evidence Foundation
Career Start Year 2008
Number of shared co-authors 3
UT Southwestern Medical Center
Career Start Year 2006
Number of shared co-authors 1
Duke University Medical Center
Career Start Year 2004
Number of shared co-authors 6
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 1
Hospital of the University of Pennsylvania
Career Start Year 2003
Number of shared co-authors 1
Institute of Health Policy Management and Evaluation, University of Toronto
Career Start Year 2003
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 1
University of Florida College of Medicine
Career Start Year 2002
Number of shared co-authors 3
Stanford University
Career Start Year 2001
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 1999
Number of shared co-authors 3
University of California-San Francisco
Career Start Year 1998
Number of shared co-authors 1
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 0
Stanford University
Career Start Year 1997
Number of shared co-authors 1
Julius Center for Health Sciences and Primary Care, UMC Utrecht, Trecht University
Career Start Year 1997
Number of shared co-authors 3
University Health Network
Career Start Year 1994
Number of shared co-authors 4
Stanford University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Geisel School of Medicine at Dartmouth
Career Start Year 1992
Number of shared co-authors 2
School of Public Health, University of Pittsburgh
Career Start Year 1988
Number of shared co-authors 0
Dartmouth Cancer Center
Career Start Year 1988
Number of shared co-authors 1
Tufts University School of Medicine
Career Start Year 1986
Number of shared co-authors 3
Vanderbilt University School of Medicine
Career Start Year 1974
Number of shared co-authors 4

Collaborators

13Center for Health Decision Sciences, Harvard T.H. Chan School of Public Health
Co-authored papers 24
Leiden University Medical Center
Co-authored papers 11
Icahn School of Medicine at Mount Sinai
Co-authored papers 10
Co-authored papers 10
Harvard T.H. Chan School of Public Health
Co-authored papers 6
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai
Co-authored papers 4
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 4
Icahn School of Medicine at Mount Sinai, NY Institute for Genomic Health
Co-authored papers 4
Center for Medical Ethics and Health Policy, Baylor College of Medicine
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai
Co-authored papers 4
University Medical Center Rotterdam
Co-authored papers 3
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Institute of Social and Preventive Medicine (I.S.P.M.), University of Bern
Co-authored papers 3
Co-authored papers 3
Cincinnati Children's Hospital Medical Center
Co-authored papers 3
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 2
University of North Carolina
Co-authored papers 2
The Institute for Genomic Health, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
University of Michigan Health System ann arbor
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Vizient Inc.
Co-authored papers 2
University of Washington
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Co-authored papers 2